AAAAAA

   
Results: 1-16 |
Results: 16
DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR PD 152247 (PNQX)EQUIVALENT CONCENTRATIONS IN RAT-BRAIN MICRODIALYSATE FLUID
Authors: BARKSDALE CM NORDBLOM GD DUDECK RC WELTY DF JORDAN S BIGGE CF YI CS
Citation: Cm. Barksdale et al., DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR PD 152247 (PNQX)EQUIVALENT CONCENTRATIONS IN RAT-BRAIN MICRODIALYSATE FLUID, Journal of clinical ligand assay, 21(3), 1998, pp. 324-330
RATIONAL DESIGN OF REAGENTS FOR DRUG (HAPTEN) IMMUNOASSAY DEVELOPMENT
Authors: NORDBLOM GD
Citation: Gd. Nordblom, RATIONAL DESIGN OF REAGENTS FOR DRUG (HAPTEN) IMMUNOASSAY DEVELOPMENT, Journal of clinical ligand assay, 21(2), 1998, pp. 247-248
PHARMACOKINETICS AND PHARMACODYNAMICS OF CI-992 FOLLOWING INTRAVENOUSAND ORAL-ADMINISTRATION TO CYNOMOLGUS MONKEYS
Authors: COOK JA BURGER PJ MICHNIEWICZ BM NORDBLOM GD HICKS GW KAPLAN C RYAN MJ
Citation: Ja. Cook et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CI-992 FOLLOWING INTRAVENOUSAND ORAL-ADMINISTRATION TO CYNOMOLGUS MONKEYS, Biopharmaceutics & drug disposition, 19(3), 1998, pp. 185-191
CROSS-REACTIVITY OF FOSPHENYTOIN IN 2 HUMAN PLASMA PHENYTOIN IMMUNOASSAYS
Authors: KUGLER AR ANNESLEY TM NORDBLOM GD KOUP JR OLSON SC
Citation: Ar. Kugler et al., CROSS-REACTIVITY OF FOSPHENYTOIN IN 2 HUMAN PLASMA PHENYTOIN IMMUNOASSAYS, Clinical chemistry, 44(7), 1998, pp. 1474-1480
ON PROBE IMMUNOAFFINITY EXTRACTION BY MATRIX-ASSISTED-LASER-DESORPTION IONIZATION MASS-SPECTROMETRY/
Authors: LIANG XL LUBMAN DM ROSSI DT NORDBLOM GD BARKSDALE CM
Citation: Xl. Liang et al., ON PROBE IMMUNOAFFINITY EXTRACTION BY MATRIX-ASSISTED-LASER-DESORPTION IONIZATION MASS-SPECTROMETRY/, Analytical chemistry, 70(3), 1998, pp. 498-503
DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR THE ORALLY-ACTIVE RENIN INHIBITOR CI-992 IN CYNOMOLGUS MONKEY AND HUMAN PLASMA
Authors: BARKSDALE CM BURGER PJ NORDBLOM GD COOK JA KIRKISH LS MICHNIEWICZ BM DUDECK RC HODGES JC KLUTCHKO SR CONNOLLY CJC
Citation: Cm. Barksdale et al., DEVELOPMENT AND VALIDATION OF A RADIOIMMUNOASSAY FOR THE ORALLY-ACTIVE RENIN INHIBITOR CI-992 IN CYNOMOLGUS MONKEY AND HUMAN PLASMA, Journal of clinical ligand assay, 20(3), 1997, pp. 251-257
PHARMACOKINETICS AND BIOAVAILABILITY OF CI-977 IN RATS AND DOGS
Authors: BARKSDALE CM COON MJ TURLUCK DA GUTTENDORF RJ NORDBLOM GD
Citation: Cm. Barksdale et al., PHARMACOKINETICS AND BIOAVAILABILITY OF CI-977 IN RATS AND DOGS, Journal of clinical ligand assay, 20(2), 1997, pp. 206-211
THE USE OF IMMUNOANALYTICAL METHODS DURING DRUG DEVELOPMENT
Authors: LEE JW NORDBLOM GD
Citation: Jw. Lee et Gd. Nordblom, THE USE OF IMMUNOANALYTICAL METHODS DURING DRUG DEVELOPMENT, Journal of clinical ligand assay, 20(1), 1997, pp. 4
SYNTHESIS OF N-DESMETHYL PNQX - ELABORATION INTO AN IMMUNOGENIC CONJUGATE AND A RADIOIODINATED LIGAND - RADIOIMMUNOASSAY FOR THE AMPA NMDA ANTAGONIST, PNQX/
Authors: BIGGE CF YI CS NORDBLOM GD
Citation: Cf. Bigge et al., SYNTHESIS OF N-DESMETHYL PNQX - ELABORATION INTO AN IMMUNOGENIC CONJUGATE AND A RADIOIODINATED LIGAND - RADIOIMMUNOASSAY FOR THE AMPA NMDA ANTAGONIST, PNQX/, Bioorganic & medicinal chemistry letters, 7(15), 1997, pp. 1979-1984
PERTURBATION OF EPIDERMAL GROWTH-FACTOR CLEARANCE AFTER RADIOIODINATION AND ITS IMPLICATIONS
Authors: KUO BS NORDBLOM GD WRIGHT DS
Citation: Bs. Kuo et al., PERTURBATION OF EPIDERMAL GROWTH-FACTOR CLEARANCE AFTER RADIOIODINATION AND ITS IMPLICATIONS, Journal of pharmaceutical sciences, 86(3), 1997, pp. 290-296
DEVELOPMENT OF A RADIOIMMUNOASSAY FOR THE NOVEL N-TYPE CALCIUM-CHANNEL BLOCKER, SNX-111 (CI-1009)
Authors: BARKSDALE CM NORDBLOM GD MILJANICH GP TARCZYHORNOCH K KRISTIPATI R KUGLER AR
Citation: Cm. Barksdale et al., DEVELOPMENT OF A RADIOIMMUNOASSAY FOR THE NOVEL N-TYPE CALCIUM-CHANNEL BLOCKER, SNX-111 (CI-1009), Journal of clinical ligand assay, 19(4), 1996, pp. 229-233
DEVELOPMENT AND VALIDATION OF 2 SOLID-PHASE ENZYME IMMUNOASSAYS (ELISA) FOR QUANTITATION OF HUMAN EPIDERMAL GROWTH-FACTORS (HEGFS)
Authors: SIZEMORE N DUDECK RC BARKSDALE CM NORDBLOM GD MUELLER WT MCCONNELL P WRIGHT DS GUGLIETTA A KUO BS
Citation: N. Sizemore et al., DEVELOPMENT AND VALIDATION OF 2 SOLID-PHASE ENZYME IMMUNOASSAYS (ELISA) FOR QUANTITATION OF HUMAN EPIDERMAL GROWTH-FACTORS (HEGFS), Pharmaceutical research, 13(7), 1996, pp. 1088-1094
DISPOSITION KINETICS OF HUMAN EPIDERMAL GROWTH-FACTOR (HEGF1-53) AND ITS TRUNCATED FRAGMENT (HEGF1-48) IN RATS
Authors: KUO BS NORDBLOM GD DUDECK RC KIRKISH LS WRIGHT DS
Citation: Bs. Kuo et al., DISPOSITION KINETICS OF HUMAN EPIDERMAL GROWTH-FACTOR (HEGF1-53) AND ITS TRUNCATED FRAGMENT (HEGF1-48) IN RATS, Drug metabolism and disposition, 24(1), 1996, pp. 96-104
CONSIDERATIONS IN THE DEVELOPMENT OF A SENSITIVE HPLC ASSAY FOR HUMANEPIDERMAL GROWTH-FACTORS IN HUMAN PLASMA
Authors: KAGEL JR ROSSI DT NORDBLOM GD DUDECK RC BARKSDALE CM KUO BS WRIGHT DS
Citation: Jr. Kagel et al., CONSIDERATIONS IN THE DEVELOPMENT OF A SENSITIVE HPLC ASSAY FOR HUMANEPIDERMAL GROWTH-FACTORS IN HUMAN PLASMA, Journal of pharmaceutical and biomedical analysis, 13(10), 1995, pp. 1205-1213
THE SYNTHESES AND BINDING AFFINITIES OF TOOLS FOR THE STUDY OF ANGIOTENSIN-AT(2) RECEPTORS
Authors: HODGES JC EDMUNDS JJ NORDBLOM GD LU GH
Citation: Jc. Hodges et al., THE SYNTHESES AND BINDING AFFINITIES OF TOOLS FOR THE STUDY OF ANGIOTENSIN-AT(2) RECEPTORS, Bioorganic & medicinal chemistry letters, 3(5), 1993, pp. 905-908
A FINAL WORD OF THANKS
Authors: NORDBLOM GD
Citation: Gd. Nordblom, A FINAL WORD OF THANKS, Journal of clinical immunoassay, 16(4), 1993, pp. 255-255
Risultati: 1-16 |